Investments (Tables)

9 Months Ended

Sep. 30, 2023

Summary of Marketable Equity Securities

Marketable equity securities as of September 30, 2023 and December 31, 2022 are as follows:

	Cost		Cost of Shares Sold			Gross Unrealized Gain (Loss)			Fair Value
Marketable equity securities, September 30, 2023	$	743,902	$	(552,244	)	$	6,436		$	198,094
Marketable equity securities, December 31, 2022	$	2,976,933	$	(2,915,813	)	$	(56,830	)	$	4,290

Schedule of Short-term Investment

	September 30, 2023		December 31, 2022		September 30, 2022
Convertible note	$	-	$	-	$	-
End of period	$	-	$	-	$	-
	September 30, 2023				September 30, 2022
Beginning of year	$	-			$	539,351
Accrued interest income on convertible debt security		-				17,753
Convertible debt and interest converted into marketable shares		-				(844,882	)
Realized gain on conversion into marketable shares		-				287,778
End of period	$	-			$	-

Schedule of Notes Receivable

	September 30, 2023			December 31, 2022		September 30, 2022
Notes receivable from Seastar Medical Holding Corporation (formerly LMAO)	$	2,254,668		$	3,807,749	$	352,771
End of period	$	2,254,668		$	3,807,749	$	352,771
	September 30, 2023					September 30, 2022
Beginning of year	$	3,807,749				$	-
Investment (repayment) in Seastar Medical Holding Corporation notes receivable (formerly LMAO)		(1,661,727	)				350,000
Accrued interest income		130,990					2,771
Allowance for losses on Seastar Medical Holding Corporation notes receivable		(22,344	)				-
End of period	$	2,254,668				$	352,771

Schedule of Long-term Investment - Debt Securities

	September 30, 2023			December 31, 2022		September 30, 2022
Symbiont.IO Note Receivable	$	-		$	1,350,000	$	2,266,521
End of period	$	-		$	1,350,000	$	2,266,521
	September 30, 2023					September 30, 2022
Beginning of year	$	1,350,000				$	2,027,178
Accrued interest income on debt securities		-					239,343
Reclassification to intangible assets (Note 11)		(2,402,542	)				-
Reversal of allowance for losses on debt security		1,052,542					-
End of period	$	-				$	2,266,521

Schedule of Long-term Investment - Equity Securities

Long-term investments for the SMHC (formerly LMAO) warrants consist of the following:

	September 30, 2023			December 31, 2022		September 30, 2022
Seastar Medical Holding Corporation (formerly LMAO) warrants	$	72,815		$	464,778	$	322,246
End of period	$	72,815		$	464,778	$	322,246
	September 30, 2023					September 30, 2022
Beginning of year	$	464,778				$	1,973,413
Unrealized loss on equity securities		(391,963	)				(1,651,167	)
End of period	$	72,815				$	322,246

Summary of Investment in Unconsolidated Affiliates

Long-term investments for the SMHC (formerly LMAO) common stock consist of the following:

	September 30, 2023			December 31, 2022		September 30, 2022
Seastar Medical Holding Corporation common stock	$	683,100		$	10,608,750	$	-
Investment in unconsolidated affiliate		-			-		17,362,125
End of period	$	683,100		$	10,608,750	$	17,362,125
	September 30, 2023					September 30, 2022
Beginning of year	$	10,608,750				$	4,676,130
Unrealized gain (loss) on equity investment		(9,925,650	)				12,685,995
End of period	$	683,100				$	17,362,125